Increased NPC1L1 and serum cholesterol in a chronic rejection rat Abstract Purpose: To measure serum cholesterol and triglyceride levels and NPC1L1 mRNA and protein as an index of cholesterol absorption during the development of chronic rejection (CR) in a rat model of intestinal transplantation.
Small bowel transplantation has evolved over the last decades from being considered an experimental procedure to become a clinically accepted therapy for patients with chronic, irreversible intestinal failure [1] . Chronic rejection (CR), a silent but progressive form of gra injury that eventually results in gra failure, remains a major concern. Transplant arteriosclerosis (TA) in the gra is the main pathological characteristic of CR [2] . Hypercholesterolemia occurs in up to 80% of patients a er transplantation, with signi cant increases in the ratio of total cholesterol to high density lipoprotein cholesterol creating an atherogenic milieu, and is implicated in the development of gra arteriosclerosis [3] [4] [5] .Immunosuppression has been regarded as an important causative agent in hypercholesterolemia, resulting in adverse cardiovascular events and atherosclerosis of large caliber vessels. Nevertheless, the pathogenic mechanisms of altered cholesterol absorption and metabolism are still unknown.
Identi cation and characterization of Niemann-Pick C1 Like 1(NPC1L1) protein has established it as essential in the intestinal cholesterol absorption process. NPC1L1 is the molecular target of ezetimibe, which is a cholesterol absorption inhibitor [6, 7] . Lack of NPC1L1 causes nearly complete protection from the development of atherosclerosis in apoE -/-mice, which provides new target for the treatment for atherosclerosis [8] .
e aim of this study was to observe the changes in serum cholesterol levels, which re ect intestinal absorption, in a rat orthotopic small bowel transplantation (OSBT) model of CR, and to evaluate the possible role of NPC1L1in the development of TA.
Materials and Methods
Inbred adult male F344 and Lewis rats, weighing 220-300g, were obtained from Vitalriver Company, Beijing, China. e donors were 30-70g smaller than the recipients. All rats were housed individually in standard animal facilities, maintained on 12-h light/dark cycles, and fed with rat chow and tap water ad libitum for one week before surgery. Food was withheld from both donor and recipient animals for 24 h prior to surgery.
e protocol was approved by the Animal Research Committee of the Nanjing University, China. All procedures were carried out in accordance with 'Principles of laboratory animal care' (NIH publication NO. 85-23, revised 1985) .
Animals were divided into two groups: Group 1 (n=20) underwent syngenic Lewis to Lewis transplantation and Group 2 (n=20) underwent allogenicF344 to Lewis transplantation as well as treatment with FK506. FK506 was intramuscularly administrated to recipients on postoperative days (POD) 0-13, 20 and 27 at a dose of 1.0 mg/kg/day [9] .
OSBT was performed using standard microvascular techniques [10] . Donor and recipient surgery were performed under anesthesia induced with 100mg/kg ketamine intraperitoneally. e entire small bowel, from the ligament of Trietz to 1cm from the ileocecal valve, was removed on a vascular pedicle consisting of the superior mesenteric artery and the portal vein. e intestinal lumen was then ushed with saline to remove debris, and the vascular bed was ushed with cold 4 o C heparinized saline.
Recipient was anesthetized in a similar fashion. A er mobilization of the inferior vena cava and the aorta from surrounding connective tissue, transplantation was performed by anastomosing the gra superior mesenteric artery to the recipient infrarenal aorta and the gra portal vein to the recipient infrarenal inferior vena cava reperfusion, the recipient's own small bowel, with its mesentery, was resected from the ligament of Treitz to the ileocecal valve and replaced with the gra by performing two primary end-to-end small bowel anastomosis. ( e cold ischemia time 35±6 minutes).
Rats were kept on a warming blanket and put under a heating lamp until recovery from anesthesia. All animals had access to regular rat chow and tap water . Death within ve days due to arterial anastomosis leakage or thrombus was considered as a technical failure and excluded. All rats were kept for a long-term observation until euthanized on POD 190. All animals were euthanized and gra s were harvested and used for histology and PCR. Blood samples were taken for cholesterol and triglyceride analysis.
ree to four micrometer tissue sections were stained with hematoxylin and eosin, as well as Trichrome Masson's stain. ey were examined by two pathologists in a blind manner. e histological scale was from 0 to 3, where 0 indicated no pathological changes and 3 indicated extreme changes. ese parameters included villous blunting, epithelial apoptotic body, muscularis and mesenteric brosis [11] . ing between 50% and 100%, with <20%luminal compromise; grade 3, 20-50% luminal compromise; grade 4, 50-80% luminal compromise; grade 5, >80% luminalcompromise [11, 12] .
Blood was obtained from the inferior vena cava at the time of euthanasia. Serum samples were analyzed for total cholesterol (TC) and triglyceride (TG) levels.
Total RNA was extracted from frozen gra bowel samples with Trizol reagent (Invitrogen, Carlsbad, California) and then measured by spectrophotometer (BioPhotometer, Eppendorf, Hamburg, German). PrimeScriptTM 1st Strand cDNA Synthesis Kit (TaKaRa, Japan) and GoTaq Colorless Master Mix (Promega, Madison, WI, USA) were used for rst strand cDNA synthesis and PCR. e transcriptions of NPC1L1
were detected with the primers in Table 1 . e transcription of β-actin was used for normalization. e PCR products were electrophoresed on 2% agarose gels and detected by ethidium bromide staining. Images were obtained and the gray values of all the products were measured by ImageJ.
Immunohistochemical study was performed using the EnVision method (Dako, Glostrup, Danmark) on 2-mm formalinxed, para n-embedded sections. Antigen retrieval was performed by incubation of the slides in 10 mM sodium citrate bu er (pH6.0) for 10 min at 95°C. Goat polyclonal antibody against ratNPC1L1 (Santa Cruz Biotechnology Inc, Santa Cruz, CA,USA) was incubated overnight in a 1:100 dilution.
Results are expressed as mean values ± SD. Student's t test was used to determine the signi cance of group di erences. P<0.05 was considered statistically signi cant.
Results s
Isogra s revealed normal macroscopic appearance and the mesenteric arteries showed normal structure. Allogra s had thickened bowel wall, bowel enlargement, feces retention, abundant mesenteric adhesions, severe mesenteric brosis and indiscernible mesenteric vessels and the mesenteric arteries in allogra s manifested numerous in ammatory in ltration and severe intimal thickening, and the diameter of lumen decreased signi cantly (Figure 1) . Allogra s demonstrated brosis at di erent levers. Severe mesenteric brosis and mild muscularis brosis were observed via Masson stain, while brosis was hardly observed in isogra s (Figure 2) .
Histologic evaluation of isogra s and allogra s was summarized in Table2. Isogra sscored 0 in all features analyzed. Compared with isogra s, the scores of allogra s displayed a signi cant di erence (P<0.001).
Author e serum TC level in the allogenic group was signi cantly higher than in the syngenic group (1.85±0.19 mmol/L vs 1.63±0.16 mmol/L, p=0.034);however, the serum TG levels in two groups were similar (Table 3 ). e expression of NPC1L1 by RT-PCR (relative to β-actin) result was 0.66±0.08 and 0.92±0.13, p=0.004, in isogra s and allogra s, respectively, suggesting a signi cant increase of NPC1L1 with the development of chronic rejection (Fig 3) .
e NPC1L1 protein mainly expressed in the brush border membrane of the enterocyte. Compared with the syngenic group, a signi cant increase of NPC1L1 in allogra s was also observed (Fig 4) .
Discussion
Development of CR, as characterized by TA, is now recognized as the predominant cause of allogra loss long-term following solid organ transplantation. TA a ects up to 50% of patients 5 years a er transplantation, as diagnosed by angiography. Pathogenesis of TA seems to be multifactorial but precise mechanisms involved in the development of this remodeling process still remain obscure [2] .
Hypercholesterolemia and abnormalities in lipid metabolism probably contribute to the chronic allogra dysfunction 3 . Hyperlipidemia is common a er cardiac transplantation a ecting 60 -80% of patients [13, 14] . An altered lipid pro le has been reported to occur in up to 80% of renal transplant recipients, and persists long a er transplantation. Posttransplant lipid pro le is characterized by a signi cant increase in TC, rendering as many as 77% of patients hypercholesterolemic [15, 16] . Many causes have been shown to contribute to hypercholesterolemia in both animal models and clinical recipients a er intestinal transplantation; CR and immunosuppression both played important roles. Currently, there was no de nite research to demonstrate their roles separately. In our study, compared with syngenic group, hypercholesterolemia occurred in all recipients of the allogenic group, while no di erence was observed in TG levels between allogenic and syngenic groups. Besides, allogra s displayed typical histological changes of TA. Histological scores con rmed signi cant di erences between isogra s and allogra s, and demonstrated that intimal thickening and mesenteric brosis were predomi- nant. e results suggested that high cholesterol levels may accelerate the development of CR. is present study uses the histological score criteria described by Orlo and coworkers, who demonstrated severe rejection in the absence of physiological intraluminal exposure to nutrients in their model of heterotopic intestinal transplantation [11] . In order to better represent the physiologic state of small intestinal function and to overcome the severe toxicity of Cyclosporine A, FK506 was used in the present study. FK506 had already been used successful in a proceeding study 9 tha twas designed to evaluate the changes in cholesterol absorption and the role of long term intragastrical supplementation with sh oil in the development of TA. During rst week a er surgery, intragastrical supplementation was shown to lead to severe diarrhea because of reperfusion injury, so a later timepoint was selected for the present study ( rst week + half a year intragastrical supplementation).
Allogra vasculopathy may begin because of endothelial damage induced by ischemia at the time of transplantation and accelerate due to hyperlipidemia or other risk factors, as seen in other models of accelerated atherosclerosis [17] . Autopsy studies have shown that the cholesterol content in transplant coronary arteries is 10-fold greater than in native vessels, and clinical studies have associated increased cholesterol levels with a greater risk of TA [2] . Hypercholesterolemia contributes to the pathology of chronic and acute rejection. Histologically ,there is arteriosclerosis of the gra vessels, with thickening of the intimal layer resulting in progressive lumen occlusion. Hypercholesterolemia has been found to accelerate the development of these vascular lesions, and is a risk factor for decline in gra function and CR [2, 3, 17] .
Absorption of cholesterol by the proximal small intestine represents a major pathway for entry of cholesterol into the body pools. In adult humans, typically several hundred milligrams of cholesterol reach the liver from the intestine daily, with the potential to impact the plasma TC concentration [18] . Identi cation and characterization of NPC1L1 has established it as an essential protein in the intestinal cholesterol absorption process. While otherwise phenotypically normal, NPC1L1null mice exhibit a signi cant reduction in the intestinal uptake and absorption of cholesterol [6, 19] . NPC1L1 null mice are resistant to diet-induced hypercholesterolemia, and when crossed with apoE null mice, were completely resistant to the development of atherosclerosis [8] . Characterization of the NPC1L1 pathway revealed that ezetimibe specically binds to NPC1L1 and inhibits its sterol transport function, and it is now widely used in combination therapy with statins for management of hypercholesterolemia in the general population [20] . In liver, cardiac and kidney transplant patients, hypercholesterolemia could be e ectively treated with ezetimibe with few side e ects [21] [22] [23] . e present study suggests that the signi cantly increased expression of NPC1L1 might promote intestinal cholesterol absorption, which might contribute to hypercholesterolemia involved in the development of CR; however, other important aspects of cholesterol metabolism were not studied simultaneously.
Immunosuppression has additional severe adverse e ects on lipid metabolism. Although tacrolimus has been shown to have a less detrimental e ect on plasma lipids than either cyclosporine orsirolimus, the assessment of interactions with immunosuppressants will be an important component of further studies. Another syngenic group, treated with FK506 to conAuthor et al. Running title © 2011 CIM Clin In E176 FIGURE 3. NPC1L1 expression of gra s evaluated using RT-PCR. e gray density of NPC1L1 in the allogenic group was signi cantly higher than in the syngenic group (0.92±0.13 and 0.66±0.08, p=0.004). e expression of NPC1L1 in isogra s was much smaller.
clusively evaluate FK506 e ects, or allogeneic transplants plus ezetimibe, to determine if ezetimde can reverse hypercholesterolemia, need to be investigated in future research. e current study focused only on intestinal cholesterol absorption, while the changes in cholesterol synthesis, transport and excretion need to be evaluated in future studies.
Conclusion
In the present study, we found that the expression of NPC1L1 was activated signi cantly, which likely promoted intestinal cholesterol absorption and increased serum cholesterol level. e changes of metabolic pathways for cholesterol mentioned above might be involved in the pathogenesis of CR, which suggests a possible therapeutic target.
